Producing viral vectors on an industrial scale

Published in the Nov-Dec 2018 issue of MedNous,
a publication of Evernow Publishing Ltd.

This year, the annual conference of the European Society of Gene and Cell Therapy carried the subtitle ‘changing the face of modern medicine.’ This was a reference to not just new therapies, but also to the latest dug production technologies. While Pharma and biotech companies aim to develop novel therapies eliminating the underlying cause of a disease and thereby healing the patient instead of just targeting the symptoms, technology companies explore innovative production systems to provide enough material to bring these modern medicines through the clinic and to commercialisation.